Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (251-260 of 330) with videos related to

Pageof 33
Sort By:
Plos One|November 17, 2011
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaLih-Fen Lue, Christopher T Schmitz, Noelle L Snyder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2011
Parkinson's disease, cortical dysfunction, and alpha-synucleinJohn N Caviness, Lih-Fen Lue, Thomas G Beach, et al.
Journal of Neurotrauma|December 28, 2012
Neurochemical profile of dementia pugilisticaTyler A Kokjohn, Chera L Maarouf, Ian D Daugs, et al.
Journal of Neuropathology and Experimental Neurology|February 4, 2014
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteersBrittany N Dugger, Joseph G Hentz, Charles H Adler, et al.
Parkinsonism & Related Disorders|July 17, 2014
Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinationsSandra A Jacobson, Trisha Morshed, Brittany N Dugger, et al.
Aging Clinical and Experimental Research|August 28, 2022
Neuropathologic validation of the Alzheimer's QuestionnaireIda Mohebpour, Michael Malek-Ahmadi, Thomas Virden, et al.
Plos One|April 5, 2013
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapyAlex E Roher, David H Cribbs, Ronald C Kim, et al.
Plos One|November 9, 2013
SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screeningAdrienne Henderson-Smith, Donald Chow, Bessie Meechoovet, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 14, 2016
Graph theory network function in Parkinson's disease assessed with electroencephalographyRene L Utianski, John N Caviness, Elisabeth C W van Straaten, et al.
Pageof 33

Showing results (251-260 of 330) with videos related to

Sort By:
Pageof 33
Plos One|November 17, 2011
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingChera L Maarouf, Ian D Daugs, Tyler A Kokjohn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaLih-Fen Lue, Christopher T Schmitz, Noelle L Snyder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2011
Parkinson's disease, cortical dysfunction, and alpha-synucleinJohn N Caviness, Lih-Fen Lue, Thomas G Beach, et al.
Journal of Neurotrauma|December 28, 2012
Neurochemical profile of dementia pugilisticaTyler A Kokjohn, Chera L Maarouf, Ian D Daugs, et al.
Journal of Neuropathology and Experimental Neurology|February 4, 2014
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteersBrittany N Dugger, Joseph G Hentz, Charles H Adler, et al.
Parkinsonism & Related Disorders|July 17, 2014
Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinationsSandra A Jacobson, Trisha Morshed, Brittany N Dugger, et al.
Aging Clinical and Experimental Research|August 28, 2022
Neuropathologic validation of the Alzheimer's QuestionnaireIda Mohebpour, Michael Malek-Ahmadi, Thomas Virden, et al.
Plos One|April 5, 2013
Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapyAlex E Roher, David H Cribbs, Ronald C Kim, et al.
Plos One|November 9, 2013
SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screeningAdrienne Henderson-Smith, Donald Chow, Bessie Meechoovet, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 14, 2016
Graph theory network function in Parkinson's disease assessed with electroencephalographyRene L Utianski, John N Caviness, Elisabeth C W van Straaten, et al.
Pageof 33